#molecular_diagnostics
LightNews LightNews
razizian65.bsky.social
🔬 Reza Azizian, Ph.D. | Experimental Phage Biologist

🦠 #Phage_therapy & #Salmonella cocktails
🧬 RPA-ELISA #molecular_diagnostics
🔬 Phage-host interactions & antibiofilm research

🎯 Seeking postdoctoral opportunities and collaborations in #phage_biology and NGS antimicrobials.
November 4, 2026 at 4:54 AM
newsen.bsky.social
Co-Diagnostics Plans Third Quarter 2026 Financial Results and Live Webcast Event#USA#Salt_Lake_City#Molecular_Diagnostics#Co-Diagnostics#CODX
Co-Diagnostics Plans Third Quarter 2026 Financial Results and Live Webcast Event
Co-Diagnostics, Inc. is set to announce its financial results for Q3 2026 on November 12, followed by a live conference call and webcast.
third-news.com
October 29, 2026 at 1:51 PM
newsen.bsky.social
Alveo Technologies and Royal GD Enhance Collaboration for Advanced Livestock Diagnostics#USA#Alameda#Molecular_Diagnostics#Alveo_Technologies#Royal_GD
Alveo Technologies and Royal GD Enhance Collaboration for Advanced Livestock Diagnostics
Alveo Technologies and Royal GD are expanding their partnership to enhance molecular diagnostics for livestock, enabling rapid disease detection across various species.
third-news.com
September 22, 2026 at 1:30 PM
newsen.bsky.social
The In Vitro Diagnostics Market Is Set to Surge to $170.10 Billion by 2031 at a 7.7% CAGR#United_States#healthcare_technology#Sheridan#Molecular_Diagnostics#In_Vitro_Diagnostics
The In Vitro Diagnostics Market Is Set to Surge to $170.10 Billion by 2031 at a 7.7% CAGR
By 2031, the in vitro diagnostics market is expected to reach $170.10 billion, driven by demand for early disease detection and advanced diagnostic technologies.
third-news.com
September 17, 2026 at 2:58 PM
newsen.bsky.social
PCR Technologies Market Set to Reach $21.43 Billion by 2031 Amidst Rapid Advancements#USA#Delray_Beach#Molecular_Diagnostics#PCR_Technologies#Digital_PCR
PCR Technologies Market Set to Reach $21.43 Billion by 2031 Amidst Rapid Advancements
The PCR technologies market is expected to grow dramatically, reaching $21.43 billion by 2031 from $15.55 billion in 2026, driven by technological advancements.
third-news.com
September 15, 2026 at 2:54 PM
newsen.bsky.social
Sepsis Diagnostics Market Expected to Grow to $1.22 Billion by 2031#USA#Delray_Beach#Molecular_Diagnostics#Sepsis_Diagnostics#Blood_Culture_Testing
Sepsis Diagnostics Market Expected to Grow to $1.22 Billion by 2031
The Sepsis Diagnostics Market is projected to reach $1.22 billion by 2031, driven by rising sepsis incidences and advancements in diagnostics.
third-news.com
September 11, 2026 at 2:33 PM
newsen.bsky.social
Co-Diagnostics Achieves Operational Milestones in Q2 2026 Financial Report#United_States#Salt_Lake_City#Molecular_Diagnostics#Co-Diagnostics#PCR_Testing
Co-Diagnostics Achieves Operational Milestones in Q2 2026 Financial Report
In its recent financial report for Q2 2026, Co-Diagnostics announced key ongoing advancements in molecular diagnostics and strategic growth initiatives.
third-news.com
August 13, 2026 at 8:07 PM
newsen.bsky.social
Cepheid Unveils New GeneXpert System at ADLM 2026, Enhancing Diagnostic Innovation#United_States#Sunnyvale#Molecular_Diagnostics#Cepheid#GeneXpert
Cepheid Unveils New GeneXpert System at ADLM 2026, Enhancing Diagnostic Innovation
At ADLM 2026, Cepheid presents the latest GeneXpert system, showcasing advancements in molecular diagnostics and user-friendly features including high-plex panel testing.
third-news.com
July 22, 2026 at 1:22 PM
newsen.bsky.social
Co-Diagnostics Secures $3 Million Through New Private Placement Initiative Under Nasdaq Protocols#United_States#Salt_Lake_City#Molecular_Diagnostics#Private_Placement#Co-Diagnostics
Co-Diagnostics Secures $3 Million Through New Private Placement Initiative Under Nasdaq Protocols
Co-Diagnostics has announced a successful $3.0 million private placement, enhancing funding for its cutting-edge molecular diagnostic technology aimed at improving healthcare outcomes.
third-news.com
May 20, 2026 at 2:58 AM
newsen.bsky.social
Global DNA Polymerase Market Forecast to Total $725.8 Million by 2035 Driven by Advancements in Precision Genomics#USA#Newark#Genomics#Molecular_Diagnostics#DNA_Polymerase
Global DNA Polymerase Market Forecast to Total $725.8 Million by 2035 Driven by Advancements in Precision Genomics
The global DNA Polymerase market is projected to grow significantly, reaching USD 725.8 million by 2035 due to rising demand in molecular diagnostics and genomic technologies.
third-news.com
May 11, 2026 at 4:51 PM
newsen.bsky.social
Cyted Health Lab Earns Prestigious CAP Accreditation for Excellence#USA#CAP_Accreditation#Molecular_Diagnostics#Wilmington,_Delaware#Cyted_Health
Cyted Health Lab Earns Prestigious CAP Accreditation for Excellence
Cyted Health, a leading molecular diagnostics firm, announces its US laboratory has received CAP accreditation, enhancing its commitment to esophageal disease detection.
third-news.com
April 16, 2026 at 11:08 AM
newsen.bsky.social
Co-Diagnostics JV CoSara Expands Distributor Network by Attending Key Conferences in India#India#Mumbai#Molecular_Diagnostics#Co-Diagnostics#CoSara_Diagnostics
Co-Diagnostics JV CoSara Expands Distributor Network by Attending Key Conferences in India
Co-Diagnostics' joint venture CoSara strengthens its distributor network in India by participating in regional conferences to promote diagnostic products.
third-news.com
January 12, 2026 at 2:46 PM
newsen.bsky.social
Seegene Strengthens Its Position in Europe with New French Subsidiary#None#France#Molecular_Diagnostics#Seegene
Seegene Strengthens Its Position in Europe with New French Subsidiary
Seegene, a leader in molecular diagnostics, has launched a new subsidiary in France, boosting its European presence and aiming to enhance local market engagement.
third-news.com
December 5, 2025 at 2:26 PM
newsen.bsky.social
Seegene Launches New Subsidiary in France to Expand European Market Presence#Paris#France#Molecular_Diagnostics#Seegene
Seegene Launches New Subsidiary in France to Expand European Market Presence
Seegene, a leader in molecular diagnostics, has established a new subsidiary in France to enhance its presence in Europe and broaden customer engagement.
third-news.com
December 5, 2025 at 2:19 PM
newsen.bsky.social
Seegene Expands European Presence with New Subsidiary in France#France#N/A#Molecular_Diagnostics#Seegene#CURECA
Seegene Expands European Presence with New Subsidiary in France
Seegene, a leader in molecular diagnostics, has announced the establishment of a new subsidiary in France to enhance its market presence and support healthcare partnerships.
third-news.com
December 5, 2025 at 8:09 AM
newsen.bsky.social
Fapon to Present Revolutionary Molecular Diagnostic Solutions at AMP 2025 Annual Meeting in Boston#USA#Boston#Molecular_Diagnostics#Fapon
Fapon to Present Revolutionary Molecular Diagnostic Solutions at AMP 2025 Annual Meeting in Boston
Fapon will unveil advanced molecular diagnostic solutions, including AI-driven enzymes, at the upcoming AMP 2025 Annual Meeting from November 11-15 in Boston.
third-news.com
November 10, 2025 at 12:40 PM
newsen.bsky.social
Point-of-Care Molecular Diagnostics Market Projected to Reach $15.2 Billion by 2033#None#Market_Growth#healthcare_technology#Molecular_Diagnostics
Point-of-Care Molecular Diagnostics Market Projected to Reach $15.2 Billion by 2033
The Point-of-Care Molecular Diagnostics market is set to grow significantly, reaching $15.2 billion by 2033, driven by innovations in healthcare technology.
third-news.com
November 4, 2025 at 5:15 PM
newsen.bsky.social
Co-Diagnostics Closes $7 Million Stock Offering to Boost Operations and Growth#United_States#Salt_Lake_City#Molecular_Diagnostics#Co-Diagnostics#CODX
Co-Diagnostics Closes $7 Million Stock Offering to Boost Operations and Growth
Co-Diagnostics, Inc. recently closed a $7 million stock offering to support its growth and operational activities, enhancing its molecular diagnostics capabilities.
third-news.com
October 29, 2025 at 4:56 PM
newsen.bsky.social
Co-Diagnostics, Inc. Announces $7 Million Direct Offering and Future Plans#USA#NASDAQ#Salt_Lake_City#Molecular_Diagnostics#Co-Diagnostics
Co-Diagnostics, Inc. Announces $7 Million Direct Offering and Future Plans
Co-Diagnostics, Inc. has announced a $7 million registered direct offering of common stock, aiming to enhance its molecular diagnostics operations. The offering price is set at $0.55 per share.
third-news.com
October 28, 2025 at 3:44 PM
newsen.bsky.social
Co-Diagnostics, Inc. Engages Investors at the Fall 2025 Conference#United_States#Salt_Lake_City#Molecular_Diagnostics#Co-Diagnostics#Lytham_Partners
Co-Diagnostics, Inc. Engages Investors at the Fall 2025 Conference
Co-Diagnostics, Inc. will present at the Lytham Partners Fall 2025 Investor Conference, focusing on its innovative molecular diagnostic technologies.
third-news.com
September 30, 2025 at 3:41 PM
newsen.bsky.social
Co-Diagnostics, Inc. Raises $3.8 Million through Direct Stock Offering to Accelerate Growth in Molecular Diagnostics#United_States#Salt_Lake_City#Molecular_Diagnostics#Co-Diagnostics#CODX
Co-Diagnostics, Inc. Raises $3.8 Million through Direct Stock Offering to Accelerate Growth in Molecular Diagnostics
Co-Diagnostics, Inc. has successfully completed a direct offering, raising $3.8 million to enhance its molecular diagnostics capabilities. This funding aims to support their growth and innovation.
third-news.com
September 18, 2025 at 9:15 PM
newsen.bsky.social
Co-Diagnostics, Inc. Unveils $3.8 Million Common Stock Offering Under Nasdaq Guidelines#United_States#NASDAQ#Salt_Lake_City#Molecular_Diagnostics#Co-Diagnostics
Co-Diagnostics, Inc. Unveils $3.8 Million Common Stock Offering Under Nasdaq Guidelines
Co-Diagnostics, Inc. has announced a direct offering of $3.8 million in common stock at an attractive price, aiming for growth and innovation in molecular diagnostics.
third-news.com
September 17, 2025 at 2:23 PM
newsen.bsky.social
The Ligase Enzymes Market: Projected Growth and Key Trends Through 2030#USA#Delray_Beach#Molecular_Diagnostics#Next-Gen_Sequencing#Ligase_Enzymes
The Ligase Enzymes Market: Projected Growth and Key Trends Through 2030
The ligase enzymes market is set to grow significantly, valued at US$0.36 billion by 2030, driven by advancements in molecular diagnostics and synthetic biology.
third-news.com
September 12, 2025 at 2:36 PM
newsen.bsky.social
Global Molecular Diagnostics Market Expected to Hit $30.74 Billion by 2030#United_States#Delray_Beach#Precision_Medicine#Molecular_Diagnostics#Genetic_Testing
Global Molecular Diagnostics Market Expected to Hit $30.74 Billion by 2030
The Molecular Diagnostics Market is forecasted to reach $30.74 billion by 2030, driven by innovations and increasing disease prevalence.
third-news.com
September 9, 2025 at 4:11 PM
newsen.bsky.social
Co-Diagnostics, Inc. Reports Declines in Revenue and Operational Losses for Q2 2025#United_States#financial_results#Salt_Lake_City#Molecular_Diagnostics#Co-Diagnostics
Co-Diagnostics, Inc. Reports Declines in Revenue and Operational Losses for Q2 2025
Co-Diagnostics, Inc. announces disappointing financial results for Q2 2025, reporting a significant drop in revenue and increased operational losses amidst ongoing developments.
third-news.com
August 14, 2025 at 8:20 PM